Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC
Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC
Recruiting · NCT05332925 · Registry updated 2024-02-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung cancer, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Not stated | 2024-02-23 | NCT05332925 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jun Zhang, MD, PhD | 3 |
| Nilogen Oncosystems | 1 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The University of Kansas Cancer Center (KUCC) | Fairway | United States | 4 |
| The University of Kansas Cancer Center, Westwood Campus | Kansas City | United States | 6 |